C Difficile

9693 bookmarks
Newest
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey - PubMed
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey - PubMed
The gut microbiota play a pivotal role in human health. Dysbiosis, alterations in microbiota composition and function, is associated with gastrointestinal disorders, including inflammatory bowel disease (IBD). This international survey aimed to assess physicians' experiences, perceptions, and practi …
·pubmed.ncbi.nlm.nih.gov·
Efficacy, Safety, and Concerns on Microbiota Modulation, Antibiotics, Probiotics, and Fecal Microbial Transplant for Inflammatory Bowel Disease and Other Gastrointestinal Conditions: Results from an International Survey - PubMed
Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection
Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection
Nature Communications - Antibiotics can cause hospital-acquired diarrhoea, resulting in gut microbiota and metabolome changes. Here, the authors study the faecal microbiota and metabolome of 169...
·news.google.com·
Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection
A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units - PubMed
A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units - PubMed
The Gram-positive anaerobic bacterium Clostridioides difficile (CD) can produce intense exotoxins, contributing to nosocomial infections, and it is the most common cause of health-care-associated infectious diarrhea. Based on spontaneous Individual Case Safety Reports from EudraVigilance (EV) …
·pubmed.ncbi.nlm.nih.gov·
A Pharmacovigilance Study Regarding the Risk of Antibiotic-Associated Clostridioides difficile Infection Based on Reports from the EudraVigilance Database: Analysis of Some of the Most Used Antibiotics in Intensive Care Units - PubMed
Therapies from Thiopeptides - PubMed
Therapies from Thiopeptides - PubMed
The first part of this contribution describes solutions that were developed to achieve progressively more efficient syntheses of the thiopeptide natural products, micrococcins P1 and P2 (MP1-MP2), with an eye toward exploring their potential as a source of new antibiotics. Such efforts enabled inves …
·pubmed.ncbi.nlm.nih.gov·
Therapies from Thiopeptides - PubMed
The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health - PubMed
The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health - PubMed
The most critical phase of human microbiome development is in the first 2-3 years of life. Preventing and treating dysbiosis during pregnancy and early life can have a profound effect on an infant's later health.
·pubmed.ncbi.nlm.nih.gov·
The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health - PubMed
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer - PubMed
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer - PubMed
The gastrointestinal microbiome has been shown to play a key role in determining the responses to cancer immunotherapy, including immune checkpoint inhibitor (ICI) therapy and CAR-T. In patients with non-small cell lung cancer (NSCLC), increasing evidence suggests that a microbiome composition signa …
·pubmed.ncbi.nlm.nih.gov·
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer - PubMed
Trauma-toxicology: concepts, causes, complications - PubMed
Trauma-toxicology: concepts, causes, complications - PubMed
Trauma and toxic substances are connected in several aspects. On the one hand, toxic substances can be the reason for traumatic injuries in the context of accidental or violent and criminal circumstances. Examples for the first scenario is the release of toxic gases, chemicals, and particles during …
·pubmed.ncbi.nlm.nih.gov·
Trauma-toxicology: concepts, causes, complications - PubMed
A Colonic Organoid Model Challenged with the Large Toxins of Clostridioides difficile TcdA and TcdB Exhibit Deregulated Tight Junction Proteins - PubMed
A Colonic Organoid Model Challenged with the Large Toxins of Clostridioides difficile TcdA and TcdB Exhibit Deregulated Tight Junction Proteins - PubMed
Adult stem cell-derived human colonic organoid monolayers were applicable as a colon infection model for electrophysiological measurements. The TJ changes noted can explain the epithelial barrier dysfunction and diarrhea in patients, as well as increased entry of luminal antigens triggering inflamma …
·pubmed.ncbi.nlm.nih.gov·
A Colonic Organoid Model Challenged with the Large Toxins of Clostridioides difficile TcdA and TcdB Exhibit Deregulated Tight Junction Proteins - PubMed
Impact of functional status on development of Clostridioides difficile infection and increase in in-hospital mortality among antibiotic users - PubMed
Impact of functional status on development of Clostridioides difficile infection and increase in in-hospital mortality among antibiotic users - PubMed
Assessment of functional status, especially combined with comorbidities, was significantly associated with developing CDI and may also be useful in predicting in-hospital mortality.
·pubmed.ncbi.nlm.nih.gov·
Impact of functional status on development of Clostridioides difficile infection and increase in in-hospital mortality among antibiotic users - PubMed
Role of microbiota in radiation-induced small-bowel damage - PubMed
Role of microbiota in radiation-induced small-bowel damage - PubMed
Radiation-induced gastrointestinal damage is a common acute radiation syndrome. Previous studies have highlighted that Galectin-1 and Interleukin-6 (IL-6) are associated with flaking of small intestinal villi and intestinal radioresistance. Therefore, our goal is to study whether gut bacteria regula …
·pubmed.ncbi.nlm.nih.gov·
Role of microbiota in radiation-induced small-bowel damage - PubMed
Novel C. diff structures are required for infection, offer new therapeutic targets
Novel C. diff structures are required for infection, offer new therapeutic targets
Newly discovered iron storage 'ferrosomes' inside the bacterium C. diff -- the leading cause of hospital-acquired infections -- are important for infection in an animal model and could offer new targets for antibacterial drugs. They also represent a rare demonstration of a membrane-bound structure inside a pathogenic bacterium, upsetting the biological dogma that bacteria do not contain organelles.
·news.google.com·
Novel C. diff structures are required for infection, offer new therapeutic targets
Controlling infections in hospitalized pretransplant candidates - PubMed
Controlling infections in hospitalized pretransplant candidates - PubMed
Ideally, antimicrobial therapy should be complete prior to transplantation. In situations in which completion of therapy prior to transplant is not feasible, therapy may need to be prolonged or modified. In most situations, infections can be managed similarly to the general population, although some …
·pubmed.ncbi.nlm.nih.gov·
Controlling infections in hospitalized pretransplant candidates - PubMed
Ridinilazole Emerging Drug Insights and Market Forecasts, 2019-2023 & 2023-2032
Ridinilazole Emerging Drug Insights and Market Forecasts, 2019-2023 & 2023-2032
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Ridinilazole Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about ridinilazole for clostridium difficile infection (CDI) in the seven major markets. Ridinilazole (previously known as SMT19969), being developed by Summit Therapeutics, is an investigational bisbenzimidazole oral antimicrobial that targets C. difficile whilst sparing the gut microb
·news.google.com·
Ridinilazole Emerging Drug Insights and Market Forecasts, 2019-2023 & 2023-2032
Organelles protect Clostridioides difficile from iron overdose
Organelles protect Clostridioides difficile from iron overdose
The bacterium Clostridioides difficile (C. difficile) forms organelles that help them defend against iron in the colon. According to a group of scientists from Vanderbilt University, this pathogen, which causes serious gastrointestinal infections, expresses fez genes to build structures called ferrosomes that store excess iron that is toxic to it. Its ferrosomes are surrounded by membrane and could be a target against this microorganism.
·news.google.com·
Organelles protect Clostridioides difficile from iron overdose
How this McMaster researcher is changing lives with healthy poop
How this McMaster researcher is changing lives with healthy poop
Nikhil Pai always knew he wanted to work in pediatrics. What he wasn’t expecting is how much of his work would involve poop. Pai is a pediatric gastroenterologist and an associate professor with McMaster University’s Department of Pediatrics. He considers himself a clinician-scientist. It’s a position that allows him to ask: How can I advance [...]Read More...
·news.google.com·
How this McMaster researcher is changing lives with healthy poop
Clostridioides difficile spores tolerate disinfection with sodium hypochlorite disinfectant and remain viable within surgical scrubs and gown fabrics - PubMed
Clostridioides difficile spores tolerate disinfection with sodium hypochlorite disinfectant and remain viable within surgical scrubs and gown fabrics - PubMed
Clostridioides difficile spores tolerate disinfection with sodium hypochlorite disinfectant and remain viable within surgical scrubs and gown fabrics
·pubmed.ncbi.nlm.nih.gov·
Clostridioides difficile spores tolerate disinfection with sodium hypochlorite disinfectant and remain viable within surgical scrubs and gown fabrics - PubMed
Comparison between washed microbiota transplantation and infliximab: Medical cost during long-term management in patients with inflammatory bowel disease - PubMed
Comparison between washed microbiota transplantation and infliximab: Medical cost during long-term management in patients with inflammatory bowel disease - PubMed
This study demonstrated that WMT could dramatically reduce the cost and duration of hospitalizations in the long-term sustainment in the current Chinese IBD cohort. Compared with IFX, WMT could be a good way for the patients with IBD achieving long-term sustainment and saving medical costs.
·pubmed.ncbi.nlm.nih.gov·
Comparison between washed microbiota transplantation and infliximab: Medical cost during long-term management in patients with inflammatory bowel disease - PubMed
Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile - PubMed
Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile - PubMed
Secretory (S) Immunoglobin (Ig) A is the predominant mucosal antibody, which mediates host interactions with commensal and pathogenic microbes, including Clostridioides difficile . SIgA adopts a polymeric IgA structure that is bound by secretory component (SC). Despite significance, how SIgA …
·pubmed.ncbi.nlm.nih.gov·
Engineered Secretory Immunoglobulin A provides insights on antibody-based effector mechanisms targeting Clostridiodes difficile - PubMed
Azithromycin Treatment for Acne Vulgaris: A Case Report on the Risk of Clostridioides difficile Infection - PubMed
Azithromycin Treatment for Acne Vulgaris: A Case Report on the Risk of Clostridioides difficile Infection - PubMed
BACKGROUND Clostridium difficile (C. difficile) is a gram-positive, anaerobic, spore-forming bacillus. It can lead to pseudomembranous colitis characterized by electrolyte disturbances, toxic megacolon, and septic shock. The risk of C. difficile infection is higher with use of certain classes of ant …
·pubmed.ncbi.nlm.nih.gov·
Azithromycin Treatment for Acne Vulgaris: A Case Report on the Risk of Clostridioides difficile Infection - PubMed
VIDEO: No change in concomitant medications after Rebyota for recurrent C . difficile , IBD
VIDEO: No change in concomitant medications after Rebyota for recurrent C . difficile , IBD
CHICAGO — Treatment with Rebyota did not affect concurrent medication use in patients with inflammatory bowel disease and recurrent Clostridioides difficile infection, Jessica R. Allegretti, MD, MPH, explains in this Healio video. Allegretti presented data at Digestive Disease Week on safety outcomes and concomitant medication changes after treatment with Rebyota (fecal microbiota,
·news.google.com·
VIDEO: No change in concomitant medications after Rebyota for recurrent C . difficile , IBD